BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Lymphoma AND HMGA1, MGC4242, 3159, ENSG00000137309, MGC12816, HMGIY, P17096, MGC4854, HMG-R
25 results:

  • 1. Gene Expression Profiling of Mycosis Fungoides in Early and Tumor Stage-A Proof-of-Concept Study Using Laser Capture/Single Cell Microdissection and NanoString Analysis.
    Lai J; Li J; Gniadecki R; Lai R
    Cells; 2021 Nov; 10(11):. PubMed ID: 34831413
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Critical role of the high mobility group A proteins in hematological malignancies.
    De Martino M; Esposito F; Fusco A
    Hematol Oncol; 2022 Feb; 40(1):2-10. PubMed ID: 34637548
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Increased Incidence of Human Papillomavirus-Related Precancer or Second Malignancy Among Allogeneic Stem Cell Transplantation Patients: A SEER-Medicare Population Study.
    Zhao H; Duan Z; Li M; Chiao E; Ahmed S; Shih YT; Hwang JP
    Transplant Cell Ther; 2021 Dec; 27(12):1016.e1-1016.e9. PubMed ID: 34474166
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. NRF1-regulated CircNSUN2 promotes lymphoma progression through activating Wnt signaling pathway via stabilizing hmga1.
    Wang L; Yang B; Xu Z; Song X; Gong Z; Xue S; Kong L
    Cell Cycle; 2021 May; 20(9):819-828. PubMed ID: 33858292
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. The
    De Martino M; Esposito F; Fusco A
    Cell Cycle; 2020 Nov; 19(22):2955-2959. PubMed ID: 33043837
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. LncRNA LINC00467 contributes to osteosarcoma growth and metastasis through regulating hmga1 by directly targeting miR-217.
    Ma HZ; Wang J; Shi J; Zhang W; Zhou DS
    Eur Rev Med Pharmacol Sci; 2020 Jun; 24(11):5933-5945. PubMed ID: 32572906
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. MicroRNA let‑7d‑5p rescues ovarian cancer cell apoptosis and restores chemosensitivity by regulating the p53 signaling pathway via hmga1.
    Chen YN; Ren CC; Yang L; Nai MM; Xu YM; Zhang F; Liu Y
    Int J Oncol; 2019 May; 54(5):1771-1784. PubMed ID: 30816441
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Bortezomib inhibited the progression of diffuse large B-cell lymphoma via targeting miR-198.
    Wang R; Shen J; Wang Q; Zhang M
    Biomed Pharmacother; 2018 Dec; 108():43-49. PubMed ID: 30216798
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Long-term outcome analysis of reduced-intensity allogeneic stem cell transplantation in patients with mantle cell lymphoma: a retrospective study from the EBMT lymphoma Working Party.
    Robinson SP; Boumendil A; Finel H; Peggs KS; Chevallier P; Sierra J; Finke J; Poiré X; Maillard N; Milpied N; Yakoub-Agha I; Koh M; Kröger N; Nagler A; Koc Y; Dietrich S; Montoto S; Dreger P
    Bone Marrow Transplant; 2018 May; 53(5):617-624. PubMed ID: 29335632
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. MiR-26 down-regulates TNF-α/NF-κB signalling and IL-6 expression by silencing hmga1 and MALT1.
    Chen CY; Chang JT; Ho YF; Shyu AB
    Nucleic Acids Res; 2016 May; 44(8):3772-87. PubMed ID: 27025651
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Elucidation and Pharmacological Targeting of Novel Molecular Drivers of Follicular lymphoma Progression.
    Bisikirska B; Bansal M; Shen Y; Teruya-Feldstein J; Chaganti R; Califano A
    Cancer Res; 2016 Feb; 76(3):664-74. PubMed ID: 26589882
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Re-expression of HPV16 E2 in SiHa (human cervical cancer) cells potentiates NF-κB activation induced by TNF-α concurrently increasing senescence and survival.
    Prabhavathy D; Subramanian CK; Karunagaran D
    Biosci Rep; 2015 Feb; 35(1):. PubMed ID: 25572145
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Allogeneic hematopoietic stem cell transplant for hematological malignancies from mismatched 9/10 human leukocyte antigen unrelated donors: comparison with transplants from 10/10 unrelated donors and human leukocyte antigen identical siblings.
    Michallet M; Sobh M; Serrier C; Morisset S; Labussière H; Ducastelle S; Barraco F; Gilis L; Thomas X; Nicolini FE
    Leuk Lymphoma; 2015 Apr; 56(4):999-1003. PubMed ID: 25029640
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Cell competition is a tumour suppressor mechanism in the thymus.
    Martins VC; Busch K; Juraeva D; Blum C; Ludwig C; Rasche V; Lasitschka F; Mastitsky SE; Brors B; Hielscher T; Fehling HJ; Rodewald HR
    Nature; 2014 May; 509(7501):465-70. PubMed ID: 24828041
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Inactivation of the Cdkn2a locus cooperates with hmga1 to drive T-cell leukemogenesis.
    Di Cello F; Dhara S; Hristov AC; Kowalski J; Elbahloul O; Hillion J; Roy S; Meijerink JP; Winter SS; Larson RS; Huso DL; Resar L
    Leuk Lymphoma; 2013 Aug; 54(8):1762-8. PubMed ID: 23311322
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. High mobility group A1 protein acts as a new target of Notch1 signaling and regulates cell proliferation in T leukemia cells.
    Xi Y; Li YS; Tang HB
    Mol Cell Biochem; 2013 Feb; 374(1-2):173-80. PubMed ID: 23229232
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Flavopiridol induces BCL-2 expression and represses oncogenic transcription factors in leukemic blasts from adults with refractory acute myeloid leukemia.
    Nelson DM; Joseph B; Hillion J; Segal J; Karp JE; Resar LM
    Leuk Lymphoma; 2011 Oct; 52(10):1999-2006. PubMed ID: 21728742
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. The high-mobility group A1a/signal transducer and activator of transcription-3 axis: an achilles heel for hematopoietic malignancies?
    Hillion J; Dhara S; Sumter TF; Mukherjee M; Di Cello F; Belton A; Turkson J; Jaganathan S; Cheng L; Ye Z; Jove R; Aplan P; Lin YW; Wertzler K; Reeves R; Elbahlouh O; Kowalski J; Bhattacharya R; Resar LM
    Cancer Res; 2008 Dec; 68(24):10121-7. PubMed ID: 19074878
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Activation of TLX3 and NKX2-5 in t(5;14)(q35;q32) T-cell acute lymphoblastic leukemia by remote 3'-BCL11B enhancers and coregulation by PU.1 and hmga1.
    Nagel S; Scherr M; Kel A; Hornischer K; Crawford GE; Kaufmann M; Meyer C; Drexler HG; MacLeod RA
    Cancer Res; 2007 Feb; 67(4):1461-71. PubMed ID: 17308084
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. The HMG-I oncogene causes highly penetrant, aggressive lymphoid malignancy in transgenic mice and is overexpressed in human leukemia.
    Xu Y; Sumter TF; Bhattacharya R; Tesfaye A; Fuchs EJ; Wood LJ; Huso DL; Resar LM
    Cancer Res; 2004 May; 64(10):3371-5. PubMed ID: 15150086
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.